Evaluation of the Impact of Implementing Electronic Prescription in an Oncology Referral Hospital in Recife, Brazil

Abstract

Introduction The occurrence of errors in the prescription of antineoplastic oncological drugs constitutes a serious public health problem, directly affecting patient safety. In Brazil, the Protocol for the Safety in Prescription, Use, and Administration of Medications, established in 2013, aims to improve care related to medication use in healthcare facilities. This study aims to evaluate the prescription profiles of patients undergoing antineoplastic chemotherapy treatment admitted to the Pernambuco Cancer Hospital before and after the implementation of electronic prescription.

Materials and Methods The present cross-sectional study was conducted by analyzing manual and electronic prescriptions collected from the clinical oncology ward of the Pernambuco Cancer Hospital during the periods from March to May 2016 and from June to August 2016, respectively. The data collected were extracted into a specific instrument, previously adapted for the study, containing information related to patients, prescribers, and medications. Descriptive statistics were used for data analysis.

Results Among the 694 prescriptions analyzed, prescription errors were found in at least one item, with the omission of the patients' sex and bed number being the most common findings.

Conclusion All of the prescriptions analyzed, both pre- and postcomputer standardization, contained errors in their completion. With the standardized prescriptions, a significant impact was observed in reducing these rates, especially regarding omission of items and information.

Keywords

prescriptions - medication errors - antineoplastic agents

Disclosure

The authors of the present article state that it has not been submitted for evaluation to any other journal. Additionally, they declare that the study was approved by the relevant ethics committee.

Author's Contribution

DCGF: collection and assembly of data, conception and design, data analysis and interpretation, final approval of manuscript, writing of the manuscript, and provision of study materials or patient; ALVS: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; HCAJ: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; JKNSF: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; NMFM: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; PVBM: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; RBMN: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; TCM: data analysis and interpretation, final approval of manuscript, and writing of the manuscript; MRPP: conception and design, data analysis and interpretation, final approval of manuscript, and writing of the manuscript; MASM: conception and design, final approval of manuscript, and writing of the manuscript.

Clinical Trials

None.

Publikationsverlauf

Eingereicht: 15. Juli 2024

Angenommen: 20. September 2024

Artikel online veröffentlicht:
04. Februar 2025

• References

• 1 Brasil. Ministério da Saúde. Anvisa. Fiocruz. Fhemig. Anexo 03: Protocolo de segurança na prescrição, uso e administração de medicamentos. Brasília, DF: Ministério da Saúde; 2013
• 2 Schulmeister L. Chemotherapy medication errors: descriptions, severity, and contributing factors. Oncol Nurs Forum 1999; 26 (06) 1033-1042
• 3 Miasso AI, Oliveira RC, Silva AE. et al. Prescription errors in Brazilian hospitals: a multi-centre exploratory survey. Cad Saude Publica 2009; 25 (02) 313-320
• 4 Aspden P. Institute of Medicine. (U.S.). Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors. Washington, Dc: National Academies Press; 2007: 544 (Quality Chasm Series).
• 5 Warholak TL, Queiruga C, Roush R, Phan H. Medication error identification rates by pharmacy, medical, and nursing students. Am J Pharm Educ 2011; 75 (02) 24
• 6 Brasil. Ministério da Saúde. Portaria no. 529, de 1 de Abril de 2013. Institui o Programa Nacional de Segurança do Paciente (PNSP). Diário Oficial da União, 1 abr 2013.
• 7 Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada – RDC n°. 36, de 25 de julho de 2013. Institui ações para a segurança do paciente em serviços de saúde e dá outras providências. Diário Oficial da União, 2013.
• 8 Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, Sharek PJ. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 2010; 363 (22) 2124-2134
• 9 World Health Organization. WHO Patient Safety. Forward programme, 2006–2007/World Alliance for Patient Safety. World Health Organization, 2006.
• 10 Rosa MB, Perini E, Anacleto TA, Neiva HM, Bogutchi T. Erros na prescrição hospitalar de medicamentos potencialmente perigosos. Rev Saude Publica 2009; 43 (03) 490-498
• 11 Gouvêa CS, Travassos C. Indicadores de segurança do paciente para hospitais de pacientes agudos: revisão sistemática. Cad Saude Publica 2010; 26 (06) 1061-1078
• 12 Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf 2009; 32 (05) 379-389
• 13 Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency, type, and potential clinical consequences. Int J Qual Health Care 2005; 17 (01) 15-22
• 14 Louro E, Romano-Lieber NS, Ribeiro E. Eventos adversos a antibióticos em pacientes internados em um hospital universitário. Rev Saude Publica 2007; 41 (06) 1042-1048
• 15 Miasso AI, Grou CR, De Cassiani SH, de Silva AE, Fakih FT. Erros de medicação: tipos, fatores causais e providênclas tomadas em quatro hospitais brasileiros. Rev Esc Enferm USP 2006; 40 (04) 524-532
• 16 Ridley SA, Booth SA, Thompson CM. Intensive Care Society's Working Group on Adverse Incidents. Prescription errors in UK critical care units. Anaesthesia 2004; 59 (12) 1193-1200
• 17 Cassiani SHB, Ueta J. A segurança dos pacientes na utilização da medicação. São Paulo: Artes Médicas; 2004
• 18 Araujo AEPD, Mascarenhas MBJ, Néri EDR, Dias HI, Fonteles MMDF, Almeida PCD. Análise de prescrições em maternidade pública brasileira. Rev Bras Farm Hosp Serv Saude 2014; 5 (02) 63-68
• 19 Néri EDR. Determinação do perfil dos erros de prescrição de medicamentos em um hospital universitário. [Dissertação]. Fortaleza: Faculdade de Farmácia, Odontologia e Enfermagem, Universidade Federal do Ceará; 2004
• 20 Weber D, Bueno CS, Oliveira KR. Análise de prescrições medicamentosas de um hospital de pequeno porte no noroeste do Estado do Rio Grande do Sul. Rev Cienc Farm Basica Apl 2012; 33 (01) 139-145
• 21 Jacobsen TF, Mussi MM, Silveira MPT. Análise de erros de prescrição em um hospital da Região Sul do Brasil. Rev. Bras. Farm. Hosp. Serv. Saúde São Paulo 2015; 6 (03) 23-26
• 22 Arbesú Michelena MA, Ramos Fernández M, Areces Delgado F. Pilotaje en la detección de errores de prescripción de citostáticos. Rev Cuba Farm 2004; 38 (03) 1-1
• 23 Fernandes J, Frade P, Teixeira S. Omissões na prescrição da unidade de oncologia sem prescrição electrónica do Hospital Prof. Dr. Fernando Fonseca EPE. Congresso Nacional de APFH, 2012.
• 24 Bózoli LFB, Ribeiro CM, Zoccal PLM. et al. Análise de prescrições médicas para tratamento de câncer de mama em um hospital universitário do estado de São Paulo. Rev Cienc Farm Basica Apl 2012; 35 (04) 695-700
• 25 ASHP Council on Professional Affairs. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm 2002; 59 (17) 1648-1668
• 26 Coutinho MLM, Lucena FJT, Machado MV. Análise da qualidade das prescrições de antineoplásico em um hospital público do Brasil. Rev Bras Farm 2011; 95 (02) 661-675
• 27 Brasil. Lei N°. 9,787, de 10 de fevereiro de 1999. Dispõe sobre a vigilância sanitária, estabelece o medicamento genérico, dispõe sobre a utilização de nomes genéricos em produtos farmacêuticos e dá outras providências. Diário Oficial da União, 1999.
• 28 Aguiar G, da Silva Júnior LA, Magalhães Ferreira MA. Ilegibilidade e ausência de informação nas prescrições médicas: fatores de risco relacionados a erros de medicação. Rev Bras Promoc Saude 2006; 19 (02) 84-91
• 29 Cohen MR, Smetzer JL. Preventing dispensing errors. In: Cohen MR. Editor. Medication errors. 2nd ed.. Washington: American Pharmaceutical Association; 2006: 205-34
• 30 Shekelle PG. Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Comparative effectiveness review n. 211. (prepared by the Southern California-RAND Evidence-based Practice Center under Contract n. 290–2007–10062-I) AHRQ Publication n. 13–E001-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2013.